Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Elizabeth Dunbar
ST. PAUL, Minn.

Fourth Minnesotan with meningitis sues

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

A fourth Minnesotan who contracted meningitis after being treated with a tainted steroid has filed a lawsuit against the company that manufactured the drug.

Holly Peterson of Ham Lake was hospitalized for about a week, attorney Karl Carbonne said.

Peterson was diagnosed with meningitis last month and continues to receive anti-fungal injections, he said.

"[She] now is outpatient but will continue to receive her treatments now until perhaps the first of the year, and then a further prognosis will be made," Carbonne said.

Carbonne said Peterson's case against the New England Compounding Center will likely be combined with other patients' lawsuits from several other states. He said attorneys in Michigan and Minnesota have requested that the combined case be heard in Minnesota, but attorneys won't know the venue until a federal panel makes a decision early next year.

Officials at the Minnesota Department of Health say they're now aware of 12 cases of fungal meningitis in Minnesota. More than 100 Minnesota clinics have received drugs from the Massachusetts company.

The fungal meningitis outbreak linked to the New England Compounding Center has affected people in 23 states.

Carlbonne said his client decided to file the lawsuit because she was concerned the company wouldn't be able to fairly compensate her for her suffering without one.

• Follow Elizabeth Dunbar on Twitter: http://www.twitter.com/edunbarmpr